Columnar-lined oesophagus without intestinal metaplasia: Results from a cohort with a mean follow-up of 7 years

Alimentary Pharmacology and Therapeutics

Volumn 36, Issue 3, 2012, Pages 282-289

  Dias Pereira, A ^a,b   Chaves, P ^a,b  

^a INSTITUTO PORTUGUÊS DE ONCOLOGIA DE LISBOA FRANCISCO GENTIL   (Portugal)

^b UNIVERSITY OF BEIRA INTERIOR   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

PROTON PUMP INHIBITOR;

ADOLESCENT; ADULT; ARTICLE; BARRETT ESOPHAGUS; CLINICAL ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; COLUMNAR EPITHELIUM; COLUMNAR LINED ESOPHAGUS; CONTROLLED STUDY; DEMOGRAPHY; DISEASE SURVEILLANCE; FEMALE; FOLLOW UP; GASTROESOPHAGEAL REFLUX; HUMAN; HUMAN TISSUE; INTESTINE BIOPSY; INTESTINE ENDOSCOPY; INTESTINE METAPLASIA; MALE; PATHOLOGICAL ANATOMY; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEX RATIO; SYMPTOM;

ADOLESCENT; ADULT; BARRETT ESOPHAGUS; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; METAPLASIA; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84863312991     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2012.05170.x     Document Type: Article

References (53)

1. Tileston W,. Pepticulcer of the esophagus. A J Med Sci 1906; 5: 725-30.
2. Barrett N,. Chronic pepticulcer of the oesophagus and 'oesophagitis'. Br J Surg 1950; 38: 175-82.
3. Allison PR, Johnstone AS,. The esophagus lined with gastric mucous membrane. Thorax 1953; 8: 87-101.
4. Barrett N,. The lower esophagus lined by columnar epithelium. Surgery 1957; 41: 881-94.
5. McClave SA, Boyce HW Jr, Gottfried MR,. Early diagnosis of columnar-lined esophagus: a new endoscopic diagnostic criterion. Gastrointest Endosc 1987; 33: 413-6. (Pubitemid 18018923)
6. Amano Y, Ishimura N, Furuta K, et al,. Which landmarks results in a more consistent diagnosis of Barrett's esophagus, the gastric folds or the palisade vessels? Gastrointest Endosc 2006; 64: 206-11. (Pubitemid 44081905)
7. Paull A, Trier JS, Dalton MD, Camp RC, Loeb P, Goyal RK,. The histologic spectrum of Barrett's esophagus. N Engl J Med 1976; 295: 476-80.
8. Chandrasoma P, Der R, Ma Y, Dalton P, Taira M,. Histology of the gastroesophageal junction. Am J Surg Pathol 2000; 24: 402-9.
9. Weinstein WM, Ippoliti AF,. The diagnosis of Barrett's esophagus: goblets, goblets, goblets. Gastrointest Endosc 1996; 44: 91-5. (Pubitemid 26268669)
10. Wang KK, Sampliner RE, and the Practice Parameters Committee of the American College of Gastroenterology. Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus. Am J Gastroenterol 2008; 103: 788-97 (Pubitemid 351406009)
11. Society BG. Guidelines for the diagnosis and management of Barrett's columnar-lined oesophagus. In: Gastroenterology BSo, ed. 2005. Available at:. Accessed February 22, 2012.
12. Oberg S, DeMeester TR, Peters JH, et al,. The extent of Barrett's esophagus depends on the status of the lower esophageal sphincter and the degree of esophageal acid exposure. J Thorac Cardiovasc Surg 1999; 117: 572-80. (Pubitemid 29117539)
13. Chandrasoma PT, Der R, Ma Y, Peters J, Demeester T,. Histologic classification of patients based on mapping biopsies of the gastroesophageal junction. Am J Surg Pathol 2003; 27: 929-36. (Pubitemid 36758896)
14. Harrison R, Perry I, Haddadin W, et al,. Detection of intestinal metaplasia in Barrett's esophagus: an observational comparator study suggests the need for a minimum of eight biopsies. Am J Gastroenterol 2007; 102: 1052-61.
15. Gatenby Piers AC, Ramus JR, Caygill CPJ, Shepherd NA, Watson A,. Relevance of the detection of intestinal metaplasia in non-dysplastic columnar-lined esophagus. Scand J Gastroent 2008; 43: 524-30. (Pubitemid 351536041)
16. van Sandick JW, Baak JP, van Lanschot JJ, et al,. Computerized quantitative pathology for the grading of dysplasia in surveillance biopsies of Barrett's esophagus. J Pathol 2000; 190: 177-83. (Pubitemid 30082491)
17. Cameron AJ, Souto EO, Smyrk TC,. Small adenocarcinomas of the esophagogastric junction: association with intestinal metaplasia and dysplasia. Am J Gastroenterol 2002; 97: 1375-80. (Pubitemid 34664780)
18. Spechler SJ, Sharma P, Souza RF, Inadomi JM, Shaheen NJ,. American gastroenterological association medical position statement on the management of Barrett's esophagus. Gastroenterology 2011; 140: 1084-91.
19. Chandrasoma P, Wijetunge S, DeMeester S, et al,. Columnar-lined esophagus without intestinal metaplasia has no proven risk of adenocarcinoma. Am J Surg Pathol 2012; 36: 1-7.
20. Shaheen NJ, Dulai GS, Ascher B, Mitchell KL, Schmitz SM,. Effect of a new diagnosis of Barrett's esophagus on insurance status. Am J Gastroenterol 2005; 100: 577-80. (Pubitemid 40487555)
21. Sharma P, McQuaid K, Dent J, et al,. A critical review of the diagnosis and management of Barrett's esophagus: the AGA Chicago workshop. Gastroenterology 2004; 127: 310-30. (Pubitemid 38962298)
22. Hahn HP, Blount PL, Kamrun A, et al,. Intestinal differentiation in metaplasatic, nongoblet columnar epithelium in the esophagus. Am J Surg Pathol 2009; 33: 1006-15.
23. Chaves P, Crespo M, Ribeiro C, et al,. Chromosomal analysis of Barrett's cells: demonstration of instability and detection of the metaplastic lineage involved. Mod Pathol 2007; 20: 788-96. (Pubitemid 46933442)
24. Takubo K, Aida J, Naomoto Y, et al,. Cardiac rather than intestinal-type background in endoscopic resection specimens of minute Barrett adenocarcinoma. Hum Pathol 2009; 40: 65-74.
25. Liu W, Hanh H, Odze RD, Goyal K,. Metaplastic columnar epithelium without goblet cells shows DNA content abnormalities similar to goblet cell-containing epithelium. Am J Gastroenterol 2009; 104: 816-24.
26. Riddell HR, Odze RD,. Definition of Barrett's esophagus: time for a rethink-is intestinal metaplasia dead? Am J Gastroenterol 2009; 104: 2588-94.
27. Spechler SJ, Goyal RK,. The columnar-lined esophagus, intestinal metaplasia and Norman Barrett. Gastroenterology 1996; 110: 614-21. (Pubitemid 26043897)
28. Peitz U, Vieth M, Pross M, Leodolter A, Malfertheiner P,. Cardia-type metaplasia arising in the remnant esophagus after cardia resection. Gastrointest Endosc 2004; 59: 810-7. (Pubitemid 38879307)
29. Lord RGV, Wickramasinghe K, Johansson J, Demeester SR, Brabender J, Demeester TR,. Cardiac mucosa in the remnant esophagus after esophagectomy is an acquired epithelium with Barrett's-like features. Surgery 2004; 136: 633-40. (Pubitemid 39186577)
30. Chaves P, Pereira AD, Cruz C, et al,. Recurrent columnar-lined esophageal segments-study of the phenotypic characteristics using intestinal markers. Dis Esophagus 2002; 15: 282-6. (Pubitemid 36149771)
31. Hassall E,. Cardia-type mucosa as an esophageal metaplastic condition in children: Barrett's esophagus, intestinal metaplasia-negative. J Pediatr Gastroenterol Nutr 2008; 47: 102-6.
32. Oberg S, Johansson J, Wenner J, et al,. Endoscopic surveillance of columnar- lined esophagus: frequency of intestinal metaplasia detection and impact of antireflux surgery. Ann Surg 2001; 234: 619-26. (Pubitemid 33041764)
33. Sharma P, Dent J, Armstrong D, et al,. The development and validation of an endoscopic grading system for Barrett's esophagus: the Prague C & M criteria. Gastroenterology 2006; 131: 1392-9. (Pubitemid 44708937)
34. Ormsby AH, Goldblum JR, Rice TW, et al,. Cytokeratin subsets can reliably distinguish Barrett's esophagus from intestinal metaplasia of the stomach. Hum Pathol 1999; 30: 288-94. (Pubitemid 29125148)
35. Goldblum JR,. Controversies in the diagnosis of Barrett's esophagus and Barrett-related dysplasia. One pathologist's perspective. Arch Pathol Lab Med 2010; 134: 1479-84.
36. Pereira AD, Suspiro A, Chaves P, et al,. Short segments of Barrett's epithelium and intestinal metaplasia in normal appearing oesophagogastric junctions: the same or two different entities? Gut 1998; 42: 659-62. (Pubitemid 28261052)
37. Ishimura N, Amano Y, Kinoshita Y,. Endoscopic definition of esophago-gastric junction for diagnosis of Barrett's esophagus: importance of systematic education and training. Dig Endosc 2009; 21: 213-8.
38. Chandrasoma PT, Der T, Dalton P, et al,. Distribution and significance of epithelial types in columnar-lined esophagus. Am J Surg Pathol 2001; 25: 1188-93. (Pubitemid 32777719)
39. DeMeester SR, DeMeester TR,. Columnar mucosa and intestinal metaplasia of the esophagus. fifty years of controversy. Ann Surg 2000; 231: 303-21.
40. Qualman SJ, Murray RD, McClung HJ, Lucas J,. Intestinal metaplasia is age related in Barrett's esophagus. Arch Pathol Lab Med 1990; 114: 1236-40.
41. Jeurnink SM, van Herwaarden-Lindeboom MY, Siersema PD, Fischer K, Houwen RH, van der Zee DC,. Barrett's esophagus in children: does it need more attention? Dig Liver Dis 2011; 43: 682-7.
42. Hassal E,. Columnar-lined esophagus in children. Gastroenterol Clin North Am 1997; 26: 533-48.
43. El-Serag HB, Gilger MA, Shub MD, Richardson P, Bancroft J,. The prevalence of suspected Barrett's esophagus in children and adolescents: a multicenter endoscopic study. Gastrointest Endosc 2006; 61: 671-5. (Pubitemid 44604364)
44. Hamilton SR, Yardley JH,. Regeneration of cardiac-type mucosa and acquisition of Barrett mucosa after esophagogastrostomy. Gastroenterology 1977; 72: 669-75. (Pubitemid 8097609)
45. Franchimont D, Covas A, Brasseur C, Laerhem JL, El-Nakadi I, Devière J,. Newly developed Barrett's esophagus after subtotal esophagectomy. Endoscopy 2003; 35: 850-3. (Pubitemid 37254220)
46. Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R,. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 2006; 101: 1900-20.
47. Kelty CJ, Gough MD, Van Wik Q, Stephenson TJ, Ackroyd R,. Barrett's oesophagus: intestinal metaplasia is not essential for cancer risk. Scand J Gastroenterol 2007; 42: 1271-74. (Pubitemid 47537076)
48. Wu GD, Beer DG, Moore JH, Orringer MB, Appelman HD, Traber PG,. Sucrase-isomaltase gene expression in Barrett's esophagus and adenocarcinoma. Gastroenterology 1993; 105: 837-44. (Pubitemid 23249494)
49. Regalado SP, Nambu Y, Iannettoni MD, Orringer MB, Beer DG,. Abundant expression of the intestinal protein villin in Barrett's metaplasia and esophageal adenocarcinomas. Mol Carcinog 1998; 22: 182-9. (Pubitemid 28348020)
50. Shi XY, MD, Bhagwandeen B, Leong ASY,. CDX2 and villin are useful markers of intestinal metaplasia in the diagnosis of Barrett's esophagus. Am J Clin Pathol 2008; 129: 571-7. (Pubitemid 352029276)
51. Kerkhof M, Bax DA, Moons LMG, et al,. Does CDX2 expression predict Barrett's metaplasia in oesophageal columnar epithelium without goblet cells? Aliment Pharmacol Ther 2006; 24: 1613-21. (Pubitemid 44915209)
52. Chaves P, Soares J,. What is the value of the sucrase-isomaltase expression in detecting dysplastic changes in Barrett's esophagus? In:, Giuli R, Siwert JR, Couturier D, Scarpignato C, eds. Barrett's Esophagus. Paris, France: John Libbey Eurotex, 2003, 308-12
53. DeMeester SR, Wickramasinghe KS, Lord RVN, et al,. Cytokeratin and DAS-1 immunostaining reveal similarities among cardiac mucosa, CIM, and Barrett's esophagus. Am J Gastroenterol 2002; 97: 2514-23.